It's How Medicine Should Be®
<< Previous | New Search | Return to Search Results | Next >>

Physician Profile


call (888) 352-RUSH for help arranging an appointment

David Baldwin, Jr., MD

Patient Feedback
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
Board Certification:
  • Endocrinology, Diabetes & Metabolism
  • Internal Medicine
Faculty Rank: Professor
Medical or Graduate Education: Rush Medical College
Residency: Brigham and Women's Hospital - Internal Medicine
Fellowship: University of Chicago Medical Center - Endocrinology and Metabolism
Clinical Expertise:
  • Acromegaly
  • Adrenal gland cancers
  • Adrenal gland disorders
  • Adrenal insufficiency
  • Diabetes
  • Diabetes insipidus
  • Endocrine disorders
  • Fine-needle aspiration biopsy of thyroid
  • Graves' disease
  • Hashimoto's disease
  • Hyperthyroidism
  • Hypoglycemia
  • Hypoparathyroidism
  • Parathyroid disease
  • Pituitary disorders
  • Prolactinoma
  • Thyroid cancer
  • Thyroid disease
Research Interests:
  • Inpatient management of diabetes
  • Posttransplant diabetes
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to Listings go back five years.

  1. Reducing the risk of hypoglycemia associated with intravenous insulin: experience with a computerized insulin infusion program in 4 adult intensive care units.
    Sandler V, Misiasz MR, Jones J, Baldwin D
    J Diabetes Sci Technol
    2014 Sep
  2. The Association Between Glycemic Control and Clinical Outcomes After the Kidney Transplantation.
    Ramirez SC, Maaske J, Kim Y, Neagu V, Delange S, Mazhari A, Gao W, Emanuele MA, Emanuele N, Baldwin D, Mihailescu DV
    Endocr Pract
    2014 Mar 18
  3. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action.
    Draznin B, Gilden J, Golden SH, Inzucchi SE, , Baldwin D, Bode BW, Boord JB, Braithwaite SS, Cagliero E, Dungan KM, Falciglia M, Figaro MK, Hirsch IB, Klonoff D, Korytkowski MT, Kosiborod M, Lien LF, Magee MF, Masharani U, Maynard G, McDonnell ME, Moghissi ES, Rasouli N, Rubin DJ, Rushakoff RJ, Sadhu AR, Schwartz S, Seley JJ, Umpierrez GE, Vigersky RA, Low CC, Wexler DJ
    Diabetes Care
    2013 Jul
  4. Management of hyperglycemia in hospitalized patients with renal insufficiency or steroid-induced diabetes.
    Baldwin D, Apel J.
    Curr Diab Rep. 2013
    2013 Feb
    13(1):114-20. doi: 10.1007/s11892-012-0339-7.
  5. A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency.
    Baldwin D, Zander J, Munoz C, Raghu P, DeLange-Hudec S, Lee H, Emanuele MA, Glossop V, Smallwood K, Molitch M.
    Diabetes Care. 2012
    2012 Oct
    35(10):1970-4. Epub 2012 Jun 14.
  6. Insulin in the medical management of postprandial hypoglycemia in a patient with type 2 diabetes after gastric bypass surgery.
    Schoenberger JL, Koh CK, Hor T, Baldwin D, Reddy A, Rondinelli-Hamilton L.
    Case Report Endocrinol. 2012
    2012:427565. doi: 10.1155/2012/427565. Epub 2012 Jun 28.
  7. Impact of a subcutaneous insulin protocol in the emergency department: Rush Emergency Department Hyperglycemia Intervention (REDHI).
    Munoz C, Villanueva G, Fogg L, Johnson T, Hannold K, Agruss J, Baldwin D.
    J Emerg Med. 2011
    2011 May
    40(5):493-8. doi: 10.1016/j.jemermed.2008.03.017. Epub 2008 Oct 1.
  8. Treatment of inpatient hyperglycemia beginning in the emergency department: a randomized trial using insulins aspart and detemir compared with usual care.
    Bernard JB, Munoz C, Harper J, Muriello M, Rico E, Baldwin D.
    J Hosp Med. 2011
    2011 May
    6(5):279-84. doi: 10.1002/jhm.866.
  9. Use of U-500 regular insulin via continuous subcutaneous insulin infusion: clinical practice experience.
    Reutrakul S, Brown RL, Koh CK, Hor TK, Baldwin D.
    J Diabetes Sci Technol. 2011
    2011 Jul 1
    5(4):1025-6. No abstract available.
  10. Evaluation of hospital glycemic control at US academic medical centers.
    Boord JB, Greevy RA, Braithwaite SS, Arnold PC, Selig PM, Brake H, Cuny J, Baldwin D.
    J Hosp Med. 2009
    2009 Jan
    4(1):35-44. doi: 10.1002/jhm.390.
  11. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.
    Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, Munoz C, Newton C, Peng L, Baldwin D.
    J Clin Endocrinol Metab. 2009
    2009 Feb
    94(2):564-9. doi: 10.1210/jc.2008-1441. Epub 2008 Nov 18.
Patient feedback information is available for physicians employed by Rush University Medical Center who have received 30 or more patient surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Number of Patient Surveys
Friendliness/courtesy of the care provider
Explanations the care provider gave you about your problem or condition
Concern the care provider showed for your questions or worries
Likelihood of your recommending this care provider to others
Care provider's efforts to include you in decisions about your treatment
Information the care provider gave you about medications
Instructions the care provider gave you about follow-up care
Your confidence in this care provider
Degree to which care provider talked with you using words you could understand
Amount of time the care provider spent with you
For more information about patient feedback, see the Quality Care section of the Rush University Medical Center website.